Current Research in Food Science, 9, 100810100810
The test just looks abnormal because the input (creatine) has increased
DOSING USED IN PHASE 3 STUDIES In the most recent studies from the TRIUMPH programme (Phase 3) , retatrutide was administered as follows: Route: Subcutaneous Frequency: Once weekly Study duration: Approximately 68 weeks Recommended Dosage (Clinical Research Escalation Model) Retatrutide is administered once weekly using a gradual dose escalation to improve tolerability
Allowing more glutathione to reach your cells
Stay Hydrated : Fatigue is often linked to dehydration, especially on GLP-1s
Loucks J, Zuckerman AD, Berni A, Saulles A, Thomas G, Alonzo A (2022) Proportion of days covered as a measure of medication adherence